Ángela Ibáñez Cuadrado-rekin lankidetzan egindako argitalpenak (36)

2023

  1. Identifying risk factors for predominant negative symptoms from early stages in schizophrenia: A longitudinal and sex-specific study in first-episode schizophrenia patients

    Revista de Psiquiatria y Salud Mental

  2. Obstetric complications and clinical presentation in first episode of psychosis

    Acta Neuropsychiatrica

  3. Obstetric complications and genetic risk for schizophrenia: Differential role of antenatal and perinatal events in first episode psychosis

    Acta Psychiatrica Scandinavica

  4. Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study

    European Neuropsychopharmacology, Vol. 67, pp. 53-65

  5. The polygenic basis of relapse after a first episode of schizophrenia

    European Neuropsychopharmacology, Vol. 75, pp. 80-92

2022

  1. Epigenetic clocks in relapse after a first episode of schizophrenia

    Schizophrenia, Vol. 8, Núm. 1

  2. Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients

    Schizophrenia, Vol. 8, Núm. 1

  3. The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study

    European Neuropsychopharmacology, Vol. 57, pp. 105-117

2021

  1. A longitudinal study of gene expression in first-episode schizophrenia; exploring relapse mechanisms by co-expression analysis in peripheral blood

    Translational Psychiatry, Vol. 11, Núm. 1

  2. Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis

    Schizophrenia Research, Vol. 236, pp. 19-28

  3. Premorbid Characteristics as Predictors of Early Onset Versus Adult Onset in Patients with a First Episode of Psychosis

    Journal of Clinical Psychiatry, Vol. 82, Núm. 6

  4. The prevention of relapses in first episodes of schizophrenia: The 2EPs Project, background, rationale and study design

    Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 3, pp. 164-176

  5. The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis

    Psychopharmacology, Vol. 238, Núm. 3, pp. 665-676

2020

  1. Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs study

    Schizophrenia Research, Vol. 218, pp. 292-294

  2. Influence of social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis

    Psychological Medicine, Vol. 50, Núm. 16, pp. 2702-2710

  3. Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort

    Acta Psychiatrica Scandinavica, Vol. 141, Núm. 6, pp. 541-552

2019

  1. Pharmacological treatment of obsessive compulsive disorder in adults: A clinical practice guideline based on the ADAPTE methodology

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 2, pp. 77-91

  2. Tratamiento farmacológico del transtorno obsesivo compulsivo en adultos: guía de práctica clínica (basada en el método ADAPTE)

    Editorial Ediveramerica

2018

  1. Cognitive reserve as an outcome predictor: first-episode affective versus non-affective psychosis

    Acta Psychiatrica Scandinavica, Vol. 138, Núm. 5, pp. 441-455

  2. Factors associated with poor functional outcome in bipolar disorder: sociodemographic, clinical, and neurocognitive variables

    Acta Psychiatrica Scandinavica, Vol. 138, Núm. 2, pp. 145-154